Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children. 1990

G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
Pediatric Department, University of Verona, Italy.

A double-blind study was carried out in 20 asthmatic children in order to evaluate the therapeutic efficacy and safety of inhaled corticosteroid flunisolide. 0.5 mg of the drug was administered by a jet nebulizer twice daily for 2 months. Respiratory symptoms, pulmonary function values and methacholine PC20-FEV1 were evaluated, as also morning cortisol levels, plasma cortisol increase after ACTH test, and 24-h urinary cortisol excretion. The data obtained show the efficacy of the drug in reducing symptoms. No significant difference was observed in pulmonary function values and in bronchial reactivity results between the two groups. No effect of flunisolide was observed on hypothalamic-pituitary-adrenal function. This study confirms the efficacy and safety of flunisolide (0.5 mg b.i.d.) in the treatment of asthmatic children.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005446 Fluocinolone Acetonide A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) Fluortriamcinolone Acetonide,Alvadermo,Capex,Co-Fluocin,Cortiespec,Derma-Smooth FS,Flucinar,Fluocid,Fluodermo,Fluonid,Fluotrex,Flurosyn,Flusolgen,Gelidina,Jellin,Jellisoft,Synalar,Synalar-HP,Synamol,Synemol,Acetonide, Fluocinolone,Acetonide, Fluortriamcinolone,Co Fluocin,Derma Smooth FS,Synalar HP
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
December 1981, Chest,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
July 1983, Annals of allergy,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
March 1982, Pediatrics,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
March 2003, Clinical therapeutics,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
February 1979, Annals of allergy,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
June 1974, Schweizerische medizinische Wochenschrift,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
January 1991, Padiatrie und Padologie,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
January 2010, American journal of respiratory and critical care medicine,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
January 1995, Pneumonologia i alergologia polska,
G L Piacentini, and L Sette, and D G Peroni, and C Bonizzato, and S Bonetti, and A L Boner
May 1976, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!